Philipp Koehler

Best Publications

• Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

  Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  894
  Citations

• COVID-19 associated pulmonary aspergillosis.

  Philipp Koehler;Oliver A. Cornely;Bernd W. Böttiger;Fabian Dusse

  549
  Citations

• COVID-19 associated pulmonary aspergillosis (CAPA)—from immunology to treatment

  Amir Arastehfar;Agostinho Carvalho;Frank L. van de Veerdonk;Jeffrey D. Jenks

  408
  Citations

• Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

  Martin Hoenigl;Jon Salmanton-García;Thomas J. Walsh;Thomas J. Walsh;Marcio Nucci

  391
  Citations

• Low-Avidity CD4 + T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19.

  Petra Bacher;Elisa Rosati;Daniela Esser;Gabriela Rios Martini

  311
  Citations

• COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

  Livio Pagano;Livio Pagano;Jon Salmanton-García;Francesco Marchesi;Alessandro Busca

  310
  Citations

• Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis.

  Philipp Koehler;Melanie Stecher;Oliver A Cornely;Daniela Koehler

  296
  Citations

• COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.

  Jon Salmanton-García;Rosanne Sprute;Jannik Stemler;Michele Bartoletti

  252
  Citations

• Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.

  Juergen Prattes;Joost Wauters;Daniele Roberto Giacobbe;Jon Salmanton-García

  214
  Citations

• Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM

  Unknown

  198
  Citations

• Diagnosing COVID-19-associated pulmonary aspergillosis.

  Paul E. Verweij;Jean Pierre Gangneux;Matteo Bassetti;Roger J.M. Brüggemann

  186
  Citations

• Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial

  Unknown

  153
  Citations

• Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.

  Paul E. Verweij;Paul E. Verweij;Roger J.M. Brüggemann;Elie Azoulay;Matteo Bassetti

  150
  Citations

• Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.

  Unknown

  143
  Citations

• Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19.

  Sebastian J Theobald;Alexander Simonis;Theodoros Georgomanolis;Christoph Kreer

  143
  Citations

• Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study.

  Unknown

  142
  Citations

• Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

  Unknown

  130
  Citations

• Rare mould infections caused by Mucorales, Lomentospora prolificans and Fusarium, in San Diego, CA: the role of antifungal combination therapy.

  Jeffrey D. Jenks;Sharon L. Reed;Danila Seidel;Philipp Koehler

  102
  Citations

• European candidaemia is characterised by notable differential epidemiology and susceptibility pattern; Results from the ECMM Candida III study.

  Unknown

  99
  Citations

• Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

  Philipp Koehler;Axel Hamprecht;Oliver Bader;Isabelle Bekeredjian-Ding

  96
  Citations